Fabrizio Conicella - Direttore Generale del Bioindustry Park Silvano Fumero - è intervenuto ad Explore Talks on Healthcare, che si è svolto giovedì 18 maggio presso il Polihub di Milano, con un contributo sul paradigma delle cure in medicina nel prossimo futuro.

2. Science Park and cluster managing company
focused on life sciences and health, created with
the support of Regione Piemonte in the EU
programs framework (beginning 90’s) -
Operational since 1998.
§ 25.000 sqm labs, office spaces
§ R&D shared facilities and services
§ Support and acceleration of start-up/spin
off
§ Consultancy in biomanagement
§ Networking and clustering(bioPmed)
§ Conference centre
www.bioindustrypark.eu
Key elements
Bioindustry Park
Silvano Fumero

3. The Bioindustry Park
value creation process
From the identification of promising scientific
results to the growth of a successful company:
• Incubation
• Acceleration
• Settlements
• Managerial consulting
• Clustering
• International projects
• Scientific support (outsourced)
Incubation and company
acceleration
Facility management
and General services
for lessees
Exploitation of
scientific results and
scientific services
Consulting, TT
support, Cluster
development and
International
projects

4. The Italian health
care system
• In 2000 Italy's healthcare system was regarded,
by World Health Organization's ranking, as the
2nd best in the world after France
• Healthcare is provided to all citizens and
residents by a mixed public-private system. The
public part is the national health service,
“Sistema sanitario nazionale (SSN)”, which is
organized under the Ministry of Health and is
administered on a regional basis.

5. The vision for the future
of health management
Strategic Trajectories
Areas of Scientific
& Industrial Interest
Ageing and
chronic
pathologies
Converging
technologies
Personalised
approach and
integration of
therapy
/diagnosis
New
diagnostic
systems
Prevention
Innovative
medicines and
therapeutic
approaches
E-Health
• “”4Ps” paradigm approach
• “Patient-centric” approach
• “Value based” approach

6. Health care ecosystem
Source: https://www.linkedin.com/pulse/rise-chief-
ecosystem-officer-new-leaders-innovation-health-lawer

7. “4Ps” paradigm
Prevention
Prediction
Personalisation
Participation
Personalised
healthcare
approach
Source:

8. Personalised medicine
• Genetically-determined drug response
variability
• Increased safety and efficacy
• Pharmacogenetics represents an
‘evolution’ not a ‘revolution’ in
medicine
• Increased presence of personalised
medicine, not just at a genetic level

9. “Disruptive” role of IT
▫Innovation and change element:
▫Management/analysis/visualization
of data;
▫“Ubiquitous” health management;
▫ IoT;
Source: http://qnphc.org/personalized-health-care/

10. Consequences
on the health system
• Citizens are considered in general if they
have a disease
• Patients are not empowered
• Hospitalization is the “usual” way to manage
care
• Private providers are a “premium” or a “low
cost”choice and they are solution suppliers
• Health care is based on cost management
• The citizen is considered life long
• “4ps” approach: hospitalization for
acute phases and personalized
treatment
• Advanced prevention, diagnostic,
monitoring systems
• New role for families, society and
private providers
• Health care is based on value
management
Prevention and care management
health care models
Acute phase health care models

11. Consequences at
patient level
Elements:
• Patient Empowerment
• Life long health management
• Prevention/prediction as priority
• …….
Issues:
• Privacy
• Decision power
• Cost/sustainability
• ……..

12. Potential opportunities for companies
4P
Agening Cost
pressure
Patient
empowerment
4P paradig

13. Potential opportunities for companies
New market and innovation spaces and segments e.g.
Biotech and combined products (therapeutics and diagnostics)
Telemonitoring
Private diagnostic services
New models to “manage” elderly
Prediction through analysis of genomic data
Wereables and implantables devices
Social innovation solutions for chronic diseases

14. A possible example…
Source: Josip Car, Woan Shin Tan, Zhilian Huang, Peter Sloot and Bryony Dean Franklin “eHealth in the future of medications management:
personalisation, monitoring and adherence”, BMC Medicine201715:73

15. Meet In Italy for Life Sciences

16. It is the team that wins, not
the single player
Bioindustry Park Silvano Fumero SpA
bioPmed Health Cluster
Via Ribes, 5
10010 Colleretto Giacosa (TO)
Italy
Tel. +39-0125-561311
www.bioindustrypark.eu
Info@bioindustrypark.it
www.biopmed.eu
info@biopmed.eu
Fabrizio Conicella
conicella@bioindustrypark.it
Thank you